If you have an aversion to the bitter taste of grapefruit, cabbage, broccoli and even alcohol, you might be a "super-taster," ...

People with one of five conditions are the most likely to receive up to £749.80 a month in payments from the Department for ...

Lee Hee-jae, who represented the first generation of Korean fashion models in the 1970s and 1990s, closed his eyes. Lee ...

The bile duct is a pathway in which bile produced in the liver travels through the gallbladder to the duodenum, and a ...

Partner presentations reinforce ability of proprietary Azymetric™ platform to develop clinically validated therapeutic ...

Biliary tract infection (BTI) is a disease with high morbidity and mortality, often associated with structural abnormalities such as common bile duct stones and malignant tumors. Although ...

Tovecimig combined with paclitaxel showed a 17.1% response rate in biliary tract cancer, outperforming paclitaxel alone. The COMPANION-002 study reported lower progressive disease rates with tovecimig ...

Among patients with newly diagnosed advanced biliary tract cancers (BTCs), the addition of taxane with ... benefits with GAP treatment compared to GC in locally advanced disease versus metastatic ...

THERE have been few fundamental contributions to the diagnosis and management of biliary-tract disease in recent years, but a current evaluation of the subject is justified in view of the large ...

locally advanced unresectable or metastatic biliary tract cancer in 2 cohorts. Patients received 20 mg/kg zanidatamab intravenously every 2 weeks until disease progression or unacceptable toxicity ...

Patients with locally advanced or metastatic biliary tract cancer who experience disease progression after first-line treatment typically derive limited clinical benefit from subsequent therapies.

Among the 62 patients with unresectable or metastatic HER2-positive (IHC 3+) disease, zanidatamab monotherapy ... the care of patients with biliary tract and liver cancers, I have experienced ...